Tranzyme, BD Technologies Expand HT Assay Development Partnership

genomeweb
360dx

Tranzyme, BD Technologies Expand HT Assay Development Partnership

Mar 02, 2004

NEW YORK, March 2 (GenomeWeb News) - Tranzyme Pharma today said that it has expanded a strategic alliance it began in 2002 with BD Technologies, a unit of Becton, Dickinson and Company.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Publications Highlight Findings Emerging From ClinGen Program
In Brief This Week: Myriad Genetics, Guardant Health, Personalis, and More
People in the News: Jane Schwebke, Jörg Debatin, Michel Finance
Researchers Uncover Three New Biomarkers of Active Tuberculosis
Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid
Liquid Biopsy IDs More NSCLC Mutations, Yields Patient Therapy Response in Study of Guardant Test

The Scan

Mice With Same-Sex Parents Born

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Don't Touch

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

Hong Kong's Research Funding Boost

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

This Week in Science

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.

Main menu